6533b870fe1ef96bd12d0473
RESEARCH PRODUCT
false
subject
medicine.medical_specialtyMultidisciplinaryTuberculosisCross-sectional studybusiness.industryMulti-drug-resistant tuberculosisExtensively drug-resistant tuberculosisDrug resistancemedicine.diseaseMultiple drug resistanceRegimenPharmacotherapymedicineIntensive care medicinebusinessdescription
Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases. Utilising data from three different settings (Estonia, Latvia, Romania) we sought to contrast drug susceptibility profiles for multidrug resistant tuberculosis cases, highlight the difficulties in designing universal regimen, and inform future regimen selection. Demographic and microbiological surveillance data for multidrug resistant tuberculosis cases from 2004-13 were analysed. High levels of additional resistance to currently recommended second line drugs were seen in all settings, with extensive variability between countries. Accurate drug susceptibility testing and drug susceptibility testing data are vital to inform the development of comprehensive, flexible, multidrug resistant tuberculosis guidance.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-11-11 | PLOS ONE |